Schizophrenia Research
Volume 120, Issue 1 , Pages 87-94 , July 2010

Substance use disorder comorbidity with schizophrenia in families of Mexican and Central American Ancestry

  • Lorena Jiménez-Castro

      Affiliations

    • South Texas Psychiatric Genetics Research Center, Paul L. Foster School of Medicine, Texas Tech University Health Science Center, San Antonio, TX, United States
    • Centro Investigación en Biología Molecular y Celular, University of Costa Rica, San José, Costa Rica
    • ,
  • Elizabeth Hare

      Affiliations

    • South Texas Psychiatric Genetics Research Center, Paul L. Foster School of Medicine, Texas Tech University Health Science Center, San Antonio, TX, United States
    • Neuroscience Center of Excellence, Paul L. Foster School of Medicine, Texas Tech University Health Science Center, El Paso, TX, United States
    • ,
  • Rolando Medina

      Affiliations

    • South Texas Psychiatric Genetics Research Center, Paul L. Foster School of Medicine, Texas Tech University Health Science Center, San Antonio, TX, United States
    • Department of Psychiatry, South Texas Veterans Health System, San Antonio, San Antonio, TX, United States
    • ,
  • Henriette Raventos

      Affiliations

    • Centro Investigación en Biología Molecular y Celular, University of Costa Rica, San José, Costa Rica
    • ,
  • Humberto Nicolini

      Affiliations

    • Grupo de Estudios Médicos y Familiares Carraci S.C., México DF., Mexico
    • ,
  • Ricardo Mendoza

      Affiliations

    • Department of Psychiatry and Biobehavioral Science, University of California, Los Angeles Medical Center, United States
    • ,
  • Alfonso Ontiveros

      Affiliations

    • Instituto de Información e Investigación en Salud Mental, Monterrey, Mexico
    • ,
  • Alvaro Jerez

      Affiliations

    • Centro de Investigaciones Biomédicas, Guatemala City, Guatemala
    • ,
  • Rodrigo Muñoz

      Affiliations

    • Department of Psychiatry, University of California, San Diego, CA, United States
    • ,
  • Albana Dassori

      Affiliations

    • Department of Psychiatry, South Texas Veterans Health System, San Antonio, San Antonio, TX, United States
    • ,
  • Michael Escamilla

      Affiliations

    • South Texas Psychiatric Genetics Research Center, Paul L. Foster School of Medicine, Texas Tech University Health Science Center, San Antonio, TX, United States
    • Department of Psychiatry, Paul L. Foster School of Medicine, Texas Tech University Health Science Center, El Paso, TX, United States
    • Neuroscience Center of Excellence, Paul L. Foster School of Medicine, Texas Tech University Health Science Center, El Paso, TX, United States
    • Corresponding Author InformationCorresponding author. Neuroscience Center of Excellence, Paul L. Foster School of Medicine, Texas Tech University Health Science Center, 5001 El Paso Drive, El Paso, TX 79905, United States. Tel.: +1 915 545 6831; fax: +1 210 562 5114.

Received 14 October 2009 ,Revised 8 February 2010 ,Accepted 15 February 2010.

References 

  1. Addington J, Duchak V. Reasons for substance use in schizophrenia. Acta Psychiatr. Scand. 1997;96(5):329–333
  2. Alegría M, Canino G, Shrout PE, Woo M, Duan N, Vila D, et al. Prevalence of mental illness in immigrant and non-immigrant U.S. Latino groups. Am. J. Psychiatry. 2008;165(3):359–569
  3. Alegria M, Canino G, Stinson FS, Grant BF. Nativity and DSM-IV psychiatric disorders among Puerto Ricans, Cuban Americans, and non-Latino whites in the United States: results from the National Epidemiologic Survey on Alcohol and Related Conditions. J. Clin. Psychiatry. 2006;67(1):56–65
  4. Andrade L, Caraveo-Anduaja JJ, Berglund P, Bijl RV, Kessler RC, Demler O, et al. Cross-national comparisons of the prevalences and correlates of mental disorders. WHO International Consortium in Psychiatric Epidemiology. Bull. World Health Organ. 2000;78(4):413–426
  5. Bartels SJ, Teague GB, Drake RE, Clark RE, Bush PW, Noordsy DL. Substance abuse in schizophrenia: service utilization and costs. J. Nerv. Ment. Dis. 1993;181(4):227–232
  6. Baumeister H, Härter M. Prevalence of mental disorders based on general population surveys. Soc. Psychiatry. Psychiatr. Epidemiol. 2007;42(7):537–546
  7. Bijl RV, Ravelli A, van Zessen G. Prevalence of psychiatric disorder in the general population: results of The Netherlands Mental Health Survey and Incidence Study (NEMESIS). Soc. Psychiatry. Psychiatr. Epidemiol. 1998;33(12):587–595
  8. Breslau J, Aguilar-Gaxiola S, Kendler KS, Su M, Williams D, Kessler RC. Specifying race-ethnic differences in risk for psychiatric disorder in a USA national sample. Psychol. Med. 2006;36(1):57–68
  9. Buchanan RL, Smokowski PR. Pathways from acculturation stress to substance use among Latino adolescents. Subst. Use. Misuse. 2009;44(5):740–762
  10. Cantor-Graae E, Nordström LG, McNeil TF. Substance abuse in schizophrenia: a review of the literature and a study of correlates in Sweden. Schizophr. Res. 2001;48(1):69–82
  11. Chavarría-Siles I, Contreras-Rojas J, Hare E, Walss-Bass C, Quezada P, Dassori A, et al. Cannabinoid receptor 1 gene (CNR1) and susceptibility to a quantitative phenotype for hebephrenic schizophrenia. Am. J. Med. Genet. B Neuropsychiatr. Genet. 2008;147(3):279–284
  12. Dervaux A, Baylé FJ, Laqueille X, Bourdel MC, Le Borgne MH, Olié JP, et al. Is substance abuse in schizophrenia related to impulsivity, sensation seeking, or anhedonia?. Am. J. Psychiatry. 2001;158(3):492–494
  13. Dixon L, Haas G, Weiden P, Sweeney J, Frances A. Acute effects of drug abuse in schizophrenic patients: clinical observations and patients' self-reports. Schizophr. Bull. 1990;16(1):69–79
  14. Escamilla MA, Ontiveros A, Nicolini H, Raventos H, Mendoza R, Medina R, et al. A genome-wide scan for schizophrenia and psychosis susceptibility loci in families of Mexican and Central American ancestry. Am. J. Med. Genet. B Neuropsychiatr. Genet. 2007;144(2):193–199
  15. Fowler IL, Carr VJ, Carter NT, Lewin TJ. Patterns of current and lifetime substance use in schizophrenia. Schizophr. Bull. 1998;24(3):443–455
  16. Gearon JS, Nidecker M, Bellack A, Bennett M. Gender differences in drug use behavior in people with serious mental illnesses. Am. J. Addict. 2003;12(3):229–241
  17. Grant BF, Stinson FS, Hasin DS, Dawson DA, Chou SP, Anderson K. Immigration and lifetime prevalence of DSM-IV psychiatric disorders among Mexican Americans and non-Hispanic whites in the United States: results from the National Epidemiologic Survey on Alcohol and Related Conditions. Arch. Gen. Psychiatry. 2004;61(12):1226–1233
  18. Jacobi F, Wittchen HU, Holting C, Höfler M, Pfister H, Müller N, et al. Prevalence, co-morbidity and correlates of mental disorders in the general population: results from the German Health Interview and Examination Survey (GHS). Psychol. Med. 2004;34(4):597–611
  19. Kavanagh DJ, Waghorn G, Jenner L, Chant DC, Carr V, Evans M, et al. Demographic and clinical correlates of comorbid substance use disorders in psychosis: multivariate analyses from an epidemiological sample. Schizophr. Res. 2004;66(2–3):115–124
  20. Kessler RC, Berglund P, Demler O, Jin R, Merikangas KR, Walters EE. Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication. Arch. Gen. Psychiatry. 2005;62(6):593–602
  21. Kessler RC, Birnbaum H, Demler O, Falloon IR, Gagnon E, Guyer M, et al. The prevalence and correlates of nonaffective psychosis in the National Comorbidity Survey Replication (NCS-R). Biol. Psychiatry. 2005;58(8):668–676
  22. Kessler RC, McGonagle KA, Zhao S, Nelson CB, Hughes M, Eshleman S, et al. Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Results from the National Comorbidity Survey. Arch. Gen. Psychiatry. 1994;5(1):8–19
  23. Lammertink M, Löhrer F, Kaiser R, Hambrecht M, Pukrop R. Differences in substance abuse patterns: multiple drug abuse alone versus schizophrenia with multiple drug abuse. Acta Psychiatr. Scand. 2001;104(5):361–366
  24. Levinson DF, Mowry BJ, Escamilla MA, Faraone SV. The Lifetime Dimensions of Psychosis Scale (LDPS): description and interrater reliability. Schizophr. Bull. 2002;2(4):683–695
  25. Maxwell ME. In: The Family Interview for Genetic Studies: Manual. In: Clinical Neurogenetics Branch IRP. Washington, DC: National Institute of Mental Health; 1992;
  26. McCreadie RG. Use of drugs, alcohol and tobacco by people with schizophrenia: case–control study. Br. J. Psychiatry. 2002;181(4):321–325
  27. Medina-Mora ME, Borges G, Benjet C, Lara C, Berglund P. Psychiatric disorders in Mexico: lifetime prevalence in a nationally representative sample. Br. J. Psychiatry. 2007;190(6):521–528
  28. Menezes PR, Johnson S, Thornicroft G, Marshall J, Prosser D, Bebbington P, et al. Drug and alcohol problems among individuals with severe mental illness in south London. Br. J. Psychiatry. 1996;168(5):612–619
  29. Montross LP, Barrio C, Yamada AM, Lindamer L, Golshan S, Garcia P, et al. Tri-ethnic variations of co-morbid substance and alcohol use disorders in schizophrenia. Schizophr. Res. 2005;79(2–3):297–305
  30. Mueser KT, Yarnold PR, Rosenberg SD, Swett C, Miles KM, Hill D. Substance use disorder in hospitalized severely mentally ill psychiatric patients: prevalence, correlates, and subgroups. Schizophr. Bull. 2000;26(1):179–192
  31. Nurnberger JI, Blehar MC, Kaufmann CA, York-Cooler C, Simpson SG, Harkavy-Friedman J, et al. Diagnostic interview for genetic studies. Rationale, unique features, and training. NIMH Genetics Initiative. Arch. Gen. Psychiatry. 1994;51(11):849–859
  32. Padilla E, Padilla A, Morales A, Olmedo E. Inhalant, marijuana, and alcohol abuse among barrio children and adolescents. Int. J. Addict. 1979;14(7):945–964
  33. Prado G, Huang S, Schwartz SJ, Maldonado-Molina MM, Bandiera FC, de la Rosa M, et al. What accounts for differences in substance use among U.S.-born and immigrant Hispanic adolescents?: results from a longitudinal prospective cohort study. J. Adolesc. Health. 2009;45(2):118–125
  34. Regier, D.A., Farmer, M.E., Rae, D.S., Locke, B.Z., Keith, S.J., Judd, L.L., Goodwin, F.K., 1990. Comorbidity of mental disorders with alcohol and other drug abuse. Results from the Epidemiologic Catchment Area (ECA) Study. JAMA. 264 (19), 2511–2518.
  35. Ringen PA, Melle I, Birkenaes AB, Engh JA, Faerden A, Jónsdóttir H, et al. Illicit drug use in patients with psychotic disorders compared with that in the general population: a cross-sectional study. Acta Psychiatr. Scand. 2008;117(2):133–138
  36. Rosenman S, Korten A, Medway J, Evans M. Characterising psychosis in the Australian National Survey of Mental Health and Wellbeing Study on Low Prevalence (psychotic) Disorders. Aust. N. Z. J. Psychiatry. 2000;34(5):792–800
  37. Rossi Menezes P, Ratto LR. Prevalence of substance misuse among individuals with severe mental illness in São Paulo. Soc. Psychiatry Psychiatr. Epidemiol. 2004;39(3):212–217
  38. Sartorious N, Shapiro R, Kimura M, Barrett K. WHO international pilot study of schizophrenia. Psychol. Med. 1972;2(4):422–425
  39. Soyka M, Albus M, Immler B, Kathmann N, Hippius H. Psychopathology in dual diagnosis and non-addicted schizophrenics—are there differences?. Eur. Arch. Psychiatry Clin. Neurosci. 2001;251(5):232–238
  40. Swartz MS, Wagner HR, Swanson JW, Stroup TS, McEvoy JP, Canive JM, et al. Substance use in persons with schizophrenia: baseline prevalence and correlates from the NIMH CATIE study. J. Nerv. Ment. Dis. 2006;194(3):164–172
  41. Vega WA, Canino G, Cao Z, Alegria M. Prevalence and correlates of dual diagnoses in U.S. Latinos. Drug and Alcohol Dependence. 2009;100(1–2):32–38
  42. Vega WA, Sribney WM. Achara-Abrahams I. Co-occurring alcohol, drug, and other psychiatric disorders among Mexican-origin people in the United States. Am. J. Public. Health. 2003;93(7):1057–1064
  43. Vega WA, Sribney WM, Miskimen TM, Escobar JI, Aguilar-Gaxiola S. Putative psychotic symptoms in the Mexican American population: prevalence and co-occurrence with psychiatric disorders. J. Nerv. Ment. Dis. 2006;194(7):471–477
  44. Verma SK, Subramaniam M, Chong SA, Kua EH. Substance abuse in schizophrenia. A Singapore perspective. Soc. Psychiatry Psychiatr. Epidemiol. 2002;37(7):326–328
  45. Weaver T, Renton A, Stimson G, Tyrer P. Severe mental illness and substance misuse. BMJ. 1999;318(7177):137–138
  46. Zhang AY, Snowden LR. Ethnic characteristics of mental disorders in five U.S. communities. Cultur. Divers. Ethnic. Minor. Psychol. 1999;5(2):134–146

PII: S0920-9964(10)01139-4

doi: 10.1016/j.schres.2010.02.1053

Schizophrenia Research
Volume 120, Issue 1 , Pages 87-94 , July 2010

Article Tools